Published in Gastroenterology on July 25, 2007
American Gastroenterological Association technical review on constipation. Gastroenterology (2013) 3.27
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol (2010) 2.23
Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2008) 1.93
Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain (2009) 1.80
Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis. Neuroimage (2008) 1.43
Predictors of patient-assessed illness severity in irritable bowel syndrome. Am J Gastroenterol (2008) 1.35
Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gend Med (2009) 1.28
Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology (2011) 1.22
Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles. Gastroenterology (2008) 1.14
Alpha 2 Delta (α(2)δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome. Front Pharmacol (2011) 1.06
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05
Irritable bowel syndrome: emerging paradigm in pathophysiology. World J Gastroenterol (2014) 1.03
Brain networks underlying perceptual habituation to repeated aversive visceral stimuli in patients with irritable bowel syndrome. Neuroimage (2009) 1.02
Is irritable bowel syndrome an organic disorder? World J Gastroenterol (2014) 1.01
The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials. Aliment Pharmacol Ther (2014) 1.00
Brain-gut axis: from basic understanding to treatment of IBS and related disorders. J Pediatr Gastroenterol Nutr (2012) 0.96
Relationship between rectal sensitivity, symptoms intensity and quality of life in patients with irritable bowel syndrome. Aliment Pharmacol Ther (2008) 0.94
Relation between clinical symptoms and experimental visceral hypersensitivity in pediatric patients with functional abdominal pain. J Pediatr Gastroenterol Nutr (2008) 0.90
Acupuncture-moxibustion in treating irritable bowel syndrome: how does it work? World J Gastroenterol (2014) 0.89
Reproducibility and performance characteristics of colonic compliance, tone, and sensory tests in healthy humans. Dig Dis Sci (2009) 0.88
Linaclotide - a secretagogue and antihyperalgesic agent - what next? Neurogastroenterol Motil (2010) 0.88
Thermal hypersensitivity in a subset of irritable bowel syndrome patients. World J Gastroenterol (2009) 0.86
Neuroanatomy of lower gastrointestinal pain disorders. World J Gastroenterol (2014) 0.85
Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review). Int J Mol Med (2014) 0.85
Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern. Dig Dis Sci (2011) 0.85
Endogenous inhibition of somatic pain is impaired in girls with irritable bowel syndrome compared with healthy girls. J Pain (2013) 0.82
Lessons Learnt from Post-Infectious IBS. Front Physiol (2011) 0.82
Chronic prenatal stress epigenetically modifies spinal cord BDNF expression to induce sex-specific visceral hypersensitivity in offspring. Neurogastroenterol Motil (2014) 0.81
Symptom pattern following a meal challenge test in patients with irritable bowel syndrome and healthy controls. United European Gastroenterol J (2013) 0.81
Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome. J Gastroenterol (2015) 0.81
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. J Neurogastroenterol Motil (2016) 0.79
Colokinetic effect of noradrenaline in the spinal defecation center: implication for motility disorders. Sci Rep (2015) 0.79
Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol (2016) 0.79
Altered rectal sensory response induced by balloon distention in patients with functional abdominal pain syndrome. Biopsychosoc Med (2009) 0.78
Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders. Therap Adv Gastroenterol (2010) 0.78
Rectal visceral sensitivity in women with irritable bowel syndrome without psychiatric comorbidity compared with healthy volunteers. Gastroenterol Res Pract (2009) 0.77
Irritable bowel syndrome and organic diseases: a comparative analysis of esophageal motility. World J Gastroenterol (2013) 0.77
Ischemic hypersensitivity in irritable bowel syndrome patients. Pain Med (2010) 0.77
Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients. Neurogastroenterol Motil (2016) 0.76
Visceral and somatic hypersensitivity, autonomic cardiovascular dysfunction and low-grade inflammation in a subset of irritable bowel syndrome patients. J Zhejiang Univ Sci B (2014) 0.76
New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists. Therap Adv Gastroenterol (2016) 0.76
Rectal prolapse traumatizes rectal neuromuscular microstructure explaining persistent rectal dysfunction. Int J Colorectal Dis (2016) 0.75
Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes (2016) 0.75
Esophageal Sensorimotor Function and Psychological Factors Each Contribute to Symptom Severity in Globus Patients. Am J Gastroenterol (2016) 0.75
What is the therapeutic mechanism of the probiotics in irritable bowel syndrome patients with visceral hypersensitivity? J Neurogastroenterol Motil (2014) 0.75
Biomarkers of Irritable Bowel Syndrome. J Neurogastroenterol Motil (2016) 0.75
The severity of irritable bowel syndrome or the presence of fibromyalgia influencing the perception of visceral and somatic stimuli. BMC Gastroenterol (2014) 0.75
Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead? Therap Adv Gastroenterol (2009) 0.75
Optimal management of constipation associated with irritable bowel syndrome. Ther Clin Risk Manag (2015) 0.75
Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med (2011) 6.76
The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology (2007) 4.58
Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology (2003) 3.66
Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology (2012) 3.35
The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose, and throat symptoms. Am J Gastroenterol (2004) 3.25
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J Hepatol (2013) 2.98
Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol (2002) 2.85
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut (2006) 2.82
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol (2005) 2.68
A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut (2011) 2.66
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut (2011) 2.49
Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial. Am J Gastroenterol (2010) 2.30
Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut (2013) 2.26
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol (2010) 2.23
The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. Am J Gastroenterol (2013) 2.21
Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol (2009) 2.10
Pro: Impedance testing is useful in the management of GERD. Am J Gastroenterol (2009) 2.09
Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med (2014) 2.05
Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol (2003) 2.04
Characteristics and clinical relevance of proximal esophageal pH monitoring. Am J Gastroenterol (2004) 2.01
Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol (2011) 1.93
Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res (2004) 1.88
Reproducibility and agreement of pharyngeal automated impedance manometry with videofluoroscopy. Clin Gastroenterol Hepatol (2011) 1.84
A novel method for the nonradiological assessment of ineffective swallowing. Am J Gastroenterol (2011) 1.81
Bitter taste receptors and α-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying. Proc Natl Acad Sci U S A (2011) 1.69
Nerve activity recordings in routine human intestinal biopsies. Gut (2012) 1.59
Regional brain activation during proximal stomach distention in humans: A positron emission tomography study. Gastroenterology (2005) 1.58
Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux. Am J Gastroenterol (2005) 1.56
Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion (2002) 1.51
Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol (2013) 1.50
Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol (2004) 1.50
Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease. Clin Gastroenterol Hepatol (2013) 1.47
Influence of experimentally induced anxiety on gastric sensorimotor function in humans. Gastroenterology (2005) 1.46
Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol (2005) 1.44
A pilot study of colonic B cell pattern in irritable bowel syndrome. Scand J Gastroenterol (2008) 1.42
The gendered impact of Irritable Bowel Syndrome: a qualitative study of patients' experiences. J Adv Nurs (2013) 1.41
A method to objectively assess swallow function in adults with suspected aspiration. Gastroenterology (2011) 1.35
Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol (2013) 1.34
Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology (2006) 1.33
Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut (2011) 1.32
Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus. Gut (2009) 1.31
Central nervous system involvement in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol (2004) 1.29
Relationship between anxiety and gastric sensorimotor function in functional dyspepsia. Psychosom Med (2007) 1.28
Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res (2004) 1.26
A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol (2012) 1.21
Dyspepsia: organic versus functional. J Clin Gastroenterol (2012) 1.20
Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology (2003) 1.17
A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol (2011) 1.17
Food: the forgotten factor in the irritable bowel syndrome. Gastroenterol Clin North Am (2011) 1.15
Accelerated regional bowel transit and overweight shown in idiopathic bile acid malabsorption. Am J Gastroenterol (2004) 1.15
T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol (2009) 1.15
Colonic transit time and IBS symptoms: what's the link? Am J Gastroenterol (2012) 1.14
Bile acids: short and long term effects in the intestine. Scand J Gastroenterol (2010) 1.12
Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am J Physiol Gastrointest Liver Physiol (2003) 1.12
Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces. Gut (2007) 1.11
Antibiotic therapy for the irritable bowel syndrome. N Engl J Med (2011) 1.09
Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life. Scand J Gastroenterol (2006) 1.09
Pathophysiology of functional dyspepsia. Best Pract Res Clin Gastroenterol (2004) 1.08
Imaging neuron-glia interactions in the enteric nervous system. Front Cell Neurosci (2013) 1.08
Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation. Scand J Gastroenterol (2008) 1.07
Pathogenesis of dyspepsia. Dig Dis (2008) 1.07
TRP channels in neurogastroenterology: opportunities for therapeutic intervention. Br J Pharmacol (2011) 1.07
Upper esophageal sphincter impedance as a marker of sphincter opening diameter. Am J Physiol Gastrointest Liver Physiol (2012) 1.07
Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol (2008) 1.07
The AST/ALT ratio as an indicator of cirrhosis in patients with PBC. Liver Int (2006) 1.05
Yield of 24-hour esophageal pH and bilitec monitoring in patients with persisting symptoms on PPI therapy. Dig Dis Sci (2008) 1.04
Health-related quality of life in patients attending a gastroenterology outpatient clinic: functional disorders versus organic diseases. Clin Gastroenterol Hepatol (2006) 1.04
Conservative management of esophageal perforations during pneumatic dilation for idiopathic esophageal achalasia. Clin Gastroenterol Hepatol (2011) 1.03
Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials. Am J Gastroenterol (2011) 1.03
Functional dyspepsia: past, present, and future. J Gastroenterol (2008) 1.03
Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study. BMC Gastroenterol (2011) 1.03
Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations. Clin Pharmacokinet (2011) 1.02
Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? Am J Gastroenterol (2012) 1.02
A controlled study of colonic immune activity and beta7+ blood T lymphocytes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2005) 1.02
Regional cerebral blood flow during gastric balloon distention in functional dyspepsia. Gastroenterology (2007) 1.02
Influence of motilin on gastric fundus tone and on meal-induced satiety in man: role of cholinergic pathways. Am J Gastroenterol (2006) 1.01
Fatty acid-induced gut-brain signaling attenuates neural and behavioral effects of sad emotion in humans. J Clin Invest (2011) 1.01
The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrol Dial Transplant (2002) 1.01
Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol (2003) 1.00
Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders. Clin Gastroenterol Hepatol (2004) 1.00
Overuse of acid suppressant drugs in patients with chronic renal failure. Nephrol Dial Transplant (2003) 0.99
Duodenal implications in the pathophysiology of functional dyspepsia. J Neurogastroenterol Motil (2010) 0.99
Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol (2013) 0.99
Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study. Am J Gastroenterol (2010) 0.96
Specific hunger- and satiety-induced tuning of guinea pig enteric nerve activity. J Physiol (2012) 0.96
Neurite outgrowth on cultured spiral ganglion neurons induced by erythropoietin. Hear Res (2008) 0.95
Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria. Am J Gastroenterol (2011) 0.95
Structured patient education is superior to written information in the management of patients with irritable bowel syndrome: a randomized controlled study. Eur J Gastroenterol Hepatol (2010) 0.95
Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med (2004) 0.94
The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol (2010) 0.93
Effect of bolus volume and viscosity on pharyngeal automated impedance manometry variables derived for broad Dysphagia patients. Dysphagia (2012) 0.93
Symptom patterns and pathophysiological mechanisms in dyspeptic patients with and without Helicobacter pylori. Dig Dis Sci (2003) 0.93